Ignite Creation Date:
2024-05-05 @ 4:40 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00297947
Status:
COMPLETED
Last Update Posted:
2015-04-17
First Post:
2006-02-27
Brief Title:
High Dose of Quetiapine in Treating Subjects With Treatment Refractory Schizophrenia or Schizoaffective Disorder
Sponsor:
Manhattan Psychiatric Center
Organization:
Manhattan Psychiatric Center
Organization Data
Organization:
Manhattan Psychiatric Center
Class:
OTHER
Study ID:
IRUSQUET0348
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Manhattan Psychiatric Center
Lead Sponsor Class:
OTHER
Responsible Party:
Jean-Pierre Lindenmayer
Responsible Party Title:
Clinical Director
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Manhattan Psychiatric Center
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Nathan Kline Institute for Psychiatric Research | OTHER |